Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance

被引:486
作者
Wells, AD
Li, XC
Li, YS
Walsh, MC
Zheng, XX
Wu, ZH
Nuñez, G
Tang, AM
Sayegh, M
Hancock, WW
Strom, TB
Turka, LA [1 ]
机构
[1] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[2] Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[3] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[4] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02142 USA
[5] LeukoSite Inc, Cambridge, MA 02142 USA
[6] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA
关键词
D O I
10.1038/15260
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanisms of allograft tolerance have been classified as deletion, anergy, ignorance and suppression/regulation. Deletion has been implicated in central tolerance(1), whereas peripheral tolerance has generally been ascribed to clonal anergy and/or active immunoregulatory states(2). Here, we used two distinct systems to assess the requirement for T-cell deletion in peripheral tolerance induction. in mice transgenic for Bcl-x(L), T cells were resistant to passive cell death through cytokine withdrawal, whereas T cells from interleukin-2-deficient mice did not undergo activation-induced cell death. Using either agents that block co-stimulatory pathways or the immunosuppressive drug rapamycin, which we have shown here blocks the proliferative component of interleukin-2 signaling but does not inhibit priming for activation-induced cell death, we found that mice with defective passive or active T-cell apoptotic pathways were resistant to induction of transplantation tolerance. Thus, deletion of activated T cells through activation-induced cell death or growth factor withdrawal seems necessary to achieve peripheral tolerance across major histocompatibility complex barriers.
引用
收藏
页码:1303 / 1307
页数:5
相关论文
共 24 条
[1]   CD28 COSTIMULATION CAN PROMOTE T-CELL SURVIVAL BY ENHANCING THE EXPRESSION OF BCL-X(L) [J].
BOISE, LH ;
MINN, AJ ;
NOEL, PJ ;
JUNE, CH ;
ACCAVITTI, MA ;
LINDSTEN, T ;
THOMPSON, CB .
IMMUNITY, 1995, 3 (01) :87-98
[2]  
Dai ZH, 1998, J IMMUNOL, V161, P1659
[3]   BCL-X(L) DISPLAYS RESTRICTED DISTRIBUTION DURING T-CELL DEVELOPMENT AND INHIBITS MULTIPLE FORMS OF APOPTOSIS BUT NOT CLONAL DELETION IN TRANSGENIC MICE [J].
GRILLOT, DAM ;
MERINO, R ;
NUNEZ, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) :1973-1983
[4]  
Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212
[5]   Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection [J].
Hancock, WW ;
Sayegh, MH ;
Zheng, XG ;
Peach, R ;
Linsley, PS ;
Turka, LA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :13967-13972
[6]   ANTIGEN PRESENTATION BY CHEMICALLY MODIFIED SPLENOCYTES INDUCES ANTIGEN-SPECIFIC T-CELL UNRESPONSIVENESS INVITRO AND INVIVO [J].
JENKINS, MK ;
SCHWARTZ, RH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (02) :302-319
[7]   NORMAL CLONAL EXPANSION BUT IMPAIRED FAS-MEDIATED CELL-DEATH AND ANERGY INDUCTION IN INTERLEUKIN-2-DEFICIENT MICE [J].
KNEITZ, B ;
HERRMANN, T ;
YONEHARA, S ;
SCHIMPL, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (09) :2572-2577
[8]   Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways [J].
Larsen, CP ;
Elwood, ET ;
Alexander, DZ ;
Ritchie, SC ;
Hendrix, R ;
TuckerBurden, C ;
Cho, HR ;
Aruffo, A ;
Hollenbaugh, D ;
Linsley, PS ;
Winn, KJ ;
Pearson, TC .
NATURE, 1996, 381 (6581) :434-438
[9]   INTERLEUKIN-2 PROGRAMS MOUSE ALPHA-BETA-LYMPHOCYTES-T FOR APOPTOSIS [J].
LENARDO, MJ .
NATURE, 1991, 353 (6347) :858-861
[10]   LONG-TERM SURVIVAL OF XENOGENEIC PANCREATIC-ISLET GRAFTS INDUCED BY CTLA4IG [J].
LENSCHOW, DJ ;
ZENG, YJ ;
THISTLETHWAITE, JR ;
MONTAG, A ;
BRADY, W ;
GIBSON, MG ;
LINSLEY, PS ;
BLUESTONE, JA .
SCIENCE, 1992, 257 (5071) :789-792